XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)
$0 None (None%)
Analysed XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) News Sources
Annual Report 2025
01-04-2026
yahoo.com
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
19-03-2026
yahoo.com
CORRECTION FROM SOURCE: The Nomination Committee's Proposal for New Board Members
20-02-2026
yahoo.com
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
20-02-2026
yahoo.com
Management Change at XVIVO - CFO Transitions to New Role
19-02-2026
yahoo.com
Change of Date for Publication of the Interim Report January-March 2026
10-02-2026
yahoo.com
What New Catalysts Are Reshaping the Narrative for Xvivo Perfusion?
04-12-2025
yahoo.com
Why The Narrative Around Xvivo Perfusion Is Shifting With Recent Analyst Developments
19-11-2025
yahoo.com
Interim Report January-September 2025
23-10-2025
yahoo.com
Conference Call on Interim Report July-September 2025
13-10-2025
yahoo.com
What is the current price of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The current price of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is $0.
XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) since the previous trading day is $None.
XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The most recent average sentiment score for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)?
The most recent sentiment for XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS) is .
SEC-8K** Filing Available For XVIVO PERFUSION _ UNSP ADR (XVIPY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.